Chicharros USA - bolsa internacional

Exela Technologies, Inc. Reports Preliminary Full Year and Fourth Quarter 2021 Results

• 
  
• 
  
• 
  
• 
  
• 
  
• ...
• 2021 Revenue of $1,167 million, in-line with guidance
• Loss per Share of $0.34 in the fourth quarter of 2021
• On track for $50 million in cash flow improvements in 2022
• Long-term debt(1) reduced by $454 million
• Small-and-Medium-Sized Business “SMB” continues robust growth in the fourth quarter of 2021 with DMR customers growing 44% sequentially and DrySign® users growing 135% sequentially

• Revenue: Revenue was $1,166.6 million, in-line with guidance in 2021, a decline of 9.7% from $1,292.6 million in 2020 primarily due to lower volumes and transition revenue.
  • Revenue for the Information and Transaction Processing Solutions (“ITPS”) segment was $874.2 million, representing a decline of 13.0% year-over-year.
  • Healthcare Solutions revenue was $217.8 million, a decrease of 0.5% year-over-year.
  • Legal and Loss Prevention Services revenue was $74.6 million, representing an increase of 9.1% from 2020.
  • 88% customer renewal rate in 2021.
    
    
• Operating income: Operating income in 2021 was $21.4 million, compared with an operating loss of $16.4 million in 2020. The year-over-year improvement was primarily attributable to better operating performance led by higher gross profit(2), lower SG&A costs and depreciation and amortization expenses, partially offset by higher related party expenses.
  
  
• Net Loss: Net Loss for 2021 was $142.4 million, compared with a net loss of $178.5 million in 2020. The year-over-year improvement in net loss primarily reflects the aforementioned improvement in operating income, lower interest expense and gain on extinguishment of debt.
  
  
  • EBITDA: EBITDA(3) in 2021 was $114.5 million; improved compared with EBITDA of $102.9 million in 2020. EBITDA margin for 2021 was 9.8%; improved compared with EBITDA margin of 8.0% in 2020, primarily driven by the higher operating income.
    
    
  • Adjusted EBITDA: Adjusted EBITDA(4) in 2021 was $173.3 million, compared with Adjusted EBITDA of $173.4 million in 2020. Adjusted EBITDA margin for 2021 was 14.9% compared with Adjusted EBITDA margin of 13.4% in 2020, an increase of 144 basis points.
• Capital Expenditures: Capital expenditures for 2021 were 1.4% of revenue compared to 1.2% of revenue in 2020, in-line with guidance.
  
  
• Common Stock: As of December 31, 2021, there were 265,194,961 total shares outstanding and an additional 1,309,187 shares of common stock reserved for issuance for our outstanding preferred shares on an as-converted basis.
  
  
• Total employees: 17,000 total employees as of December 31, 2021, as compared to 19,000, as of December 31, 2020.

• Revenue: Revenue for Q4 2021 was $294.3 million, a decline of 6.3% compared to $314.1 million in Q4 2020.
  • Revenue for the ITPS segment was $216.7 million, a decline of 11.0% year-over-year, primarily due to lower volumes and underutilization of resources as a result of COVID-19 and in particular to its impact on the onsite business. Exela believes it is well positioned to see these volumes return in the ITPS segment as COVID-19 impacts subside.
  • Healthcare Solutions revenue was $56.5 million, an increase of 9.5% year-over-year.
  • Legal and Loss Prevention Services revenue was $21.1 million, an increase of 11.6% year-over-year.
  • Q4 2021 DrySign user growth of 135% and DMR customer growth of 44% from Q3 2021.
  • Announced partnership with UK’s Post Office, that country's largest provider of transactional banking services with over 11,500 branches to process checks securely and expeditiously.
  • Expanded PCH Global Deployment for one of the world’s largest specialty care services insurance companies, highlighting the Company’s ability to rapidly implement PCH Global for claims submitted by providers, in this case servicing a multinational managed care.
    
    
• Operating income: Operating loss for Q4 2021 was $10.7 million, compared with operating loss of $13.9 million in Q4 2020. The year-over-year decrease in operating loss was primarily attributable to lower depreciation and amortization expenses, partially offset by lower gross profit and higher SG&A expenses.
  
  
• Net Loss: Net loss for Q4 2021 was $70.6 million, compared with a net loss of $88.9 million in Q4 2020, primarily driven by lower interest expense.
  
  
  • EBITDA: EBITDA loss for Q4 2021 was $3.1 million, compared to a loss of $8.6 million in Q4 2020. EBITDA margin for Q4 2021 was negative 1.0%, an increase of 172 basis points from negative 2.8% in Q4 2020.
    
    
  • Adjusted EBITDA: Adjusted EBITDA for Q4 2021 was $39.5 million, an increase of 6.4% compared to $37.2 million in Q4 2020. Adjusted EBITDA margin for Q4 2021 was 13.4%, an increase of 160 basis points from 11.8% in Q4 2020 and flat from 13.0% in Q3 2021.
• Capital Expenditures: Capital expenditures for Q4 2021 were 2.9% of revenue compared to 2.0% of revenue in Q4 2020.